Clinical Trial Update: Circadian Rhythm of Erythropoietin And Melatonin in Renal Disease

View source ↗

Summary

The clinical trial studying circadian rhythms of erythropoietin and melatonin in chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Erythropoietin (erythropoietin)
• Melatonin (melatonin)

Snippet

Sponsor: Meander Medical Center | Conditions: Chronic Kidney Disease | Status: COMPLETED